Cleavage of membrane-anchored proteins by ADAM (a disintegrin and metalloproteinase) endopeptidases plays a key role in a wide variety of biological signal transduction and protein turnover processes. Among ADAM family members, ADAM10 stands out as particularly important because it is both responsible for regulated proteolysis of Notch receptors and catalyzes the non-amyloidogenic a-secretase cleavage of the Alzheimer's precursor protein (APP). We present here the X-ray crystal structure of the ADAM10 ectodomain, which, together with biochemical and cellular studies, reveals how access to the enzyme active site is regulated. The enzyme adopts an unanticipated architecture in which the C-terminal cysteine-rich domain partially occludes the enzyme active site, preventing unfettered substrate access. Binding of a modulatory antibody to the cysteine-rich domain liberates the catalytic domain from autoinhibition, enhancing enzymatic activity toward a peptide substrate. Together, these studies reveal a mechanism for regulation of ADAM activity and offer a roadmap for its modulation.
In Brief
The X-ray structure of the ADAM10 ectodomain, together with biochemical and cell-based studies, reveals mechanistic insights into its enzymatic function in Notch signaling and in processing of the Alzheimer's precursor protein APP.
INTRODUCTION
Proteolytic release of membrane-tethered proteins enables cells to interpret, communicate with, and respond to their microenvironment. ADAM (a disintegrin and metalloproteinase) endopeptidases are an abundant and diverse family of type-I transmembrane metalloproteinases that hydrolyze adhesion molecules, signaling receptors, and growth factors. The human genome encodes 22 different ADAMs, essential for numerous developmental events (Weber and Saftig, 2012) including spermatogenesis, fertilization (Cho et al., 1998) , immune and gastrointestinal system development (Jones et al., 2016) , angiogenesis (Glomski et al., 2011) , and development of the CNS (Jorissen et al., 2010; Kuhn et al., 2016) . Moreover, dysregulated ADAM activity is implicated in a variety of pathophysiologic states, including asthma (Weskamp et al., 2006) , infertility (Cho et al., 1998 ), Alzheimer's disease (Suh et al., 2013) , and cancer (Murphy, 2008) .
Among ADAM family members, ADAM10 stands out as having a particularly central role in both developmental signaling and disease pathogenesis. Physiologic Notch signaling, which is transduced by regulated intramembrane proteolysis (RIP), normally relies on ADAM10 proteolysis at a juxtamembrane site (called S2), followed by g-secretase cleavage at the inner membrane leaflet at site S3 to release its intracellular domain as a transcriptional effector (Aster et al., 2017; Bray, 2016; Kovall et al., 2017) . Other important ADAM10 substrates identified from tissue-specific knockouts, cell-based studies, and proteomic analyses include N-cadherin, pro-epidermal growth factor, betacellulin, HER2, NRCAM, and ephrin receptors (Hartmann et al., 2002; Janes et al., 2005; Kuhn et al., 2016; Overall and Blobel, 2007; Reiss et al., 2005; Sahin et al., 2004) .
In disease pathogenesis, ADAM10 has been implicated in the emergence of Herceptin resistance in breast cancer (Feldinger et al., 2014; Liu et al., 2006) . It also has a prominent role in the non-amyloidogenic proteolytic shedding of the amyloid precursor protein (APP) as the major a-secretase in the CNS (Jorissen et al., 2010; Kuhn et al., 2010; Lammich et al., 1999) , and deletion of ADAM10 in mouse neural progenitor cells results in markedly reduced APP processing at the neuroprotective a-secretase site (Jorissen et al., 2010; Kuhn et al., 2010) . Recent work also reports that ADAM10 loss-of-function mutations are associated with a predisposition to the development of Alzheimer's disease (AD) (Suh et al., 2013) , suggesting that interventions leading to reduced ADAM10 activity in the brain may promote the disease, whereas stimulating ADAM10 activity in brain might inhibit development or progression of AD (Lammich et al., 1999; Postina et al., 2004) . The ability to modulate ADAM10 activity pharmacologically, however, has been hampered by the lack of structural information about the ADAM10 catalytic domain and its regulation.
ADAMs are single-pass transmembrane proteins with a modular domain organization. ADAM10 and its closest homolog, ADAM17, have an ectodomain that contains an N-terminal signal sequence and an adjacent prodomain, followed by metalloproteinase, disintegrin, and cysteine-rich domains ( Figure 1A ). The fulllength ADAM precursors are catalytically inactive when the prodomain is intact and associated with the mature enzyme. Previous characterization of both ADAM10 and ADAM17 suggests that the disintegrin and cysteine-rich domains also have an autoregulatory role (Pan and Rubin, 1997) , suppressing metalloproteinase activity in the absence of substrates (Stawikowska et al., 2013; Tape et al., 2011) . These domains may also direct enzymatic activity by binding proteolytic substrates directly (Janes et al., 2005) . Despite the profound importance of ADAM10 in both neurodegenerative disease and Notch signaling, no structural data are currently available for the full-length ectodomain of this protein, leaving unresolved the question of how disintegrin and cysteine-rich domains modulate ADAM activity.
Here, we use X-ray crystallography to determine the structure of the complete ADAM10 ectodomain in isolation and in complex with a non-modulatory antibody at resolutions of 2.8 Å and 3.1 Å , respectively. In both structures, the enzyme adopts a closed conformation in which the cysteine-rich domain precludes access of substrates to the active site. We find that catalytically inactive forms of ADAM10 containing the disintegrin and cysteine-rich domains have dominant-negative inhibitory effects on activity. Conversely, an antibody with an epitope overlapping the autoinhibitory interface enhances the catalytic activity of the enzyme. Together, these studies reveal the molecular basis for regulation of ADAM10 proteolysis and provide a roadmap for its therapeutic modulation in neurodegenerative diseases and cancer.
RESULTS

Overall Structure of ADAM10
In order to elucidate the basis for ADAM10 substrate selectivity and its potential modulation by the disintegrin and cysteinerich domains, we determined the structure of the mature ADAM10 ectodomain to 2.8 Å resolution by X-ray crystallography ( Figure 1 ; Table 1 ). Four copies of the protein are present in the asymmetric unit ( Figure S1A ). Remarkably, these are arranged as two pairs of protomers in which the C-terminal tail of one protomer extends into the active site of its partner, mimicking a peptide substrate. The metalloprotease domains of the four protomers are highly similar to one another, with pairwise root-mean-square deviation (RMSD) values of 0.4-0.5 Å (over 741 peptide backbone atoms; Figure S1B ). The interdomain arrangement is preserved in each of the four copies, with only subtle differences observed in the orientation of the disintegrin domain with respect to its flanking metalloproteinase and cysteine-rich domains.
The ADAM10 extracellular domain adopts a compact conformation that resembles an arrowhead, with the metalloproteinase domain enveloped by the disintegrin and cysteine-rich (D+C) domains ( Figure 1A ). The structure likely represents an autoinhibited conformation (see below), because the location of the cysteine-rich domain at the mouth of the peptide-binding groove partially occludes the active site, restricting access of substrate to the specificity pocket for the residue that immediately follows the scissile bond ( Figure 1A ). The D+C domains contain little secondary structure and adopt a cupped shape, rigidified by a disulfide-bond network and a conserved Ca 2+ -binding loop as in the isolated D+C region of bovine ADAM10 (PDB: 5L0Q) (Atapattu et al., 2016) . Remarkably, the overall architecture of the ADAM10 ectodomain is completely different from that of its non-catalytic homolog ADAM22 (PDB: 3G5C) (Liu et al., 2009) , the only other ADAM ectodomain of known structure ( Figure 1B ). While the individual domains are structurally similar, superimposition of the catalytic domains of ADAM10 and ADAM22 shows striking divergence in the organization of the domains relative to one another. The D+C region of ADAM22 engages a completely different surface of the metalloprotease domain from that observed in our structure, wrapping around its base to situate the cysteine-rich domain on the opposite end of the region corresponding to the catalytic groove ( Figure 1B ). In ADAM22, the two domains can assume this interdomain arrangement because there is a 5-residue linker between them, but there is no analogous linker in ADAM10. Because the architectural differences between ADAM10 and ADAM22 are so striking, we also determined the structure of a complex between ADAM10 and the F ab portion of a functionally silent antibody called 11G2 (Arduise et al., 2008) to 3.1 Å by X-ray crystallography (Table 1) . Importantly, the structure shows that the overall architecture of ADAM10 in complex with 11G2 is indistinguishable from that of isolated ADAM10 ( Figure S1C ). The F ab binds to the disintegrin domain 40 Å away from the metalloprotease active site and is equally removed from the cysteinerich domain, consistent with the observation that it does not modulate ADAM10 activity or function. The specificity of 11G2 for human ADAM10 likely results in part from the recognition of ADAM10 residue R493 by 11G2 heavy chain residues in complementaritydetermining loops two and three, including W52, which makes van der Waals contacts, and D98, which lies within hydrogen bonding distance ( Figure S1D ). In complementary studies, the ADAM10-11G2 F ab complex was visualized by negative stain electron microscopy (EM) and single-particle averaging, producing a 3D reconstruction that is in excellent agreement with our crystallographic studies. The optimal fit of the X-ray structure into the independent EM 3D model ( Figure S2 ) confirms that the autoinhibited architecture of ADAM10 seen in the X-ray structures is representative of its preferred conformation in solution.
Catalytic Domain and Substrate Recognition
The ADAM10 catalytic domain has key structural features found in active sites of other representative enzymes from the ADAM, matrix metalloprotease, and snake-venom metalloprotease families. The metalloprotease domain core is anchored by a five-stranded b sheet, the edge of which lines one side of the active site cleft (Figure 2A ). Below the cleft is a central helix, which defines the ''base'' of the active site. As in other adamalysins, this helix includes the HExxH motif that supplies two of the histidines that coordinate the bound zinc ion (H383 and H387) and the glutamate residue (E384) that participates in acid/base catalysis, with the third histidine of the zinc binding motif (H393) situated on the loop following this helix (Figure 2A ). C-terminal to the extended zinc-binding motif is a conserved methionine turn that packs against the zinc-binding site, burying the M417 side chain as a hydrophobic plug beneath the histidine residues that coordinate the zinc ion. Each enzyme active site in the crystal is occupied by the C-terminal end of a neighboring protein subunit. One of the zinc-coordination sites is filled by the terminal carboxylate oxygen from residue G655 0 (where the prime nomenclature indicates a residue in the neighboring subunit). The presence of this terminal carboxylate indicates that the C-terminal histidine tag used to facilitate purification was cleaved off during isolation or crystallization of the protein, resulting in fortuitous capture of an enzyme-product complex (Figures 2B and 2C) . Protease substrate selectivity is determined by enzyme pockets, denoted by S, that recognize substrate residues, denoted by P, followed by numbers indicating the number of substrate residues N-terminal to the cleavage site. The addition of a prime symbol (e.g., S1
0 and P1 0 ) indicates positions C-terminal to the cleavage site. The small S1 pocket, occupied in the structure by G655 0 , is consistent with the preference for alanine at the P1 position in cleavage experiments performed using peptide libraries (Caescu et al., 2009; Tucher et al., 2014) . Main chain hydrogen bonds, formed between L654 0 of the bound peptide and A331 of the edge strand (b4) that lines the active site pocket, position L654 0 into a poorly defined S2 pocket, which is likely to accommodate a variety of different side chains. In contrast, there is a well-defined hydrophobic S3 pocket bounded by L301, L330, and W332 that surrounds P653 0 at the P3 position, consistent with the observed preference for proline and other hydrophobic residues at P3 (Caescu et al., 2009; Tucher et al., 2014) .
The pocket most important for ADAM10 substrate selectivity is the S1 0 site, which exhibits a strong preference for large hydrophobic residues (Caescu et al., 2009; Tucher et al., 2014) . In the X-ray structure, the S1 0 cavity is a deep hydrophobic canyon bounded by V376, I379, T380, I416, and T422, readily explaining the preference for bulky hydrophobic residues, including the aromatic residues phenylalanine and tyrosine, at P1 0 . In contrast, the S1 0 cavity of ADAM17 is shallower, constrained by Ala439 and Val440 ( Figure 2D ), and prefers smaller, non-aromatic hydrophobic residues (Caescu et al., 2009; Tucher et al., 2014) . Binding of a Modulatory Antibody Relieves ADAM10 Autoinhibition The structure of ADAM10 suggests that the cysteine-rich domain precludes access of protein substrates to the S1 0 and S2 0 pockets, resulting in autoinhibition (Figures 2B and 2C) . Conservation analysis shows that the catalytic cleft and the interface between the cysteine-rich domain and the catalytic domain are conserved, suggesting functional importance (Figures 3A and 3B) . To evaluate the autoinhibition model further, we assayed the catalytic activity of the enzyme using a fluorogenic peptide substrate in the presence and absence of the modulatory antibody 8C7. This antibody binds to a site on the cysteine-rich domain, and the X-ray structure (Atapattu et al., 2016 ) of a complex between the 8C7 F ab and the isolated D+C region of bovine ADAM10, missing the protease domain, has been solved previously ( Figure 3C ). Superposition of the intact ADAM10 ectodomain onto this structure reveals that the ADAM10 catalytic domain and 8C7 heavy chain would overlap, resulting in a substantial steric clash ( Figure 3D ). Therefore, 8C7 binding is sterically incompatible with the autoinhibitory interface, and any conformational change in ADAM10 sufficient to relieve the clash would then result in activation of the enzyme through exposure of the active site. Strikingly, binding of 8C7 to ADAM10 does indeed enhance the catalytic activity of the enzyme toward the peptide substrate, in contrast to the non-perturbing control antibody 11G2, which does not affect the activity of the enzyme toward the same substrate ( Figure 3E ). Binding of the 8C7 antibody thus relieves ADAM10 autoinhibition toward a peptide substrate, as predicted from the structure; this conclusion is also reinforced by a previous report that the rate of association of the 8C7 antibody with the isolated D+C domain is more rapid in the absence of the metalloprotease domain than in its presence (Atapattu et al., 2012) .
Catalytically Inactive Proteins Containing the D+C Region Show Dominant-Negative Activity
To test whether the D+C region exerts an inhibitory effect on the cleavage of ADAM10 substrates in cells, we first employed a well-established Notch signaling co-culture assay using DLL4 as ligand to stimulate the activation of a Notch-responsive reporter gene. When cells expressing a Notch1-Gal4 chimera are stimulated with DLL4-expressing cells, a 15-fold induction of the luciferase reporter gene is observed. When a catalytically inactive variant of ADAM10 bearing the E384A active site mutation is co-transfected into the receptor-expressing cells, there is a dose-dependent attenuation of the reporter signal ( Figures 4A  and 4B ). To test whether this inhibitory effect is exerted by the isolated D+C region, we examined truncated proteins lacking the ADAM10 catalytic domain (DMP), or lacking the entire extracellular region (DEC). The attenuation of the Notch response by the DMP-ADAM10 protein is comparable to that observed using the E384A protein, whereas the DEC protein does not inhibit Notch activation ( Figures 4A and 4B ).
To examine whether the inhibitory activity is specific to the D+C region of ADAM10, we compared the DMP region of ADAM17, which attenuates ADAM17-mediated shedding of TNFa (Solomon et al., 1999) to that of ADAM10 in the Notch activation assay ( Figure 4C ). In contrast to DMP-ADAM10, which significantly suppresses Notch activation, DMP-ADAM17 does not ( Figure 4C ). Together, these data show that the ADAM10 D+C region exerts a specific inhibitory effect on ADAM10 proteolysis when present in the Notch expressing cell.
To test the importance of the D+C region in regulating ADAM10 activity toward another substrate, we developed an assay to measure the proteolysis of amyloid precursor protein (APP) and tested the effects of the ADAM10 variants. Upon transfection of APP into U2OS cells, the extracellular portion of APP is released from the cell surface into the culture media (Figure 4D) . Treatment of APP expressing cells with the metalloproteinase inhibitor BB94 suppresses APP shedding into the media and leads to accumulation of mature APP in the cells ( Figure 4D ). When co-transfected with APP, the catalytically inactive E384A and DMP forms of ADAM10 reduce APP ectodomain shedding, whereas the co-transfection of DEC does not ( Figures 4D and  S3A ). These results reinforce the importance of the ADAM10 disintegrin and cysteine-rich domains in regulating the processing of diverse substrates.
ADAM10 Proteolysis of Notch Occurs in cis ADAM family proteins have been shown to function largely in cis, cleaving substrate proteins within the plasma membrane of the same cell. However, it has been suggested that ADAM10 acts in trans from the ligand-bearing cell to cleave ephrin-A5 on neighboring receptor-bearing cells (Janes et al., 2005) . To test whether ADAM10 cleavage of Notch occurs in cis or in trans, we engineered an ADAM10 À/À null U2OS cell line with the CRISPR/Cas9 system ( Figures S3B and S3C ) for use in a series of co-culture reporter assays. The absence of ADAM10 dramatically reduces the response of ADAM10 À/À U2OS cells expressing the Notch1-gal4 chimera to DLL4-expressing sender cells when compared to parental cells expressing Notch1-gal4 (Figure 5A ). This signaling defect is fully rescued by restoration of ADAM10 to the Notch-expressing ADAM10 À/À cells, indicating that ADAM10 is indeed required for Notch activation in U2OS cells ( Figure 5A ). Next, we tested whether ADAM10 acts in cis or in trans to execute S2 cleavage of Notch, by expressing different combinations of ligand and receptor in parental and ADAM10 À/À cells ( Figures 5B and 5C ). When Notch and ADAM10 are not present in cis, reporter activity is again dramatically reduced. In line with prior studies (Bozkulak and Weinmaster, 2009; van Tetering et al., 2009) , these data firmly establish that ADAM10 and Notch must be present in the same cell (i.e., in cis) for activation to occur.
DISCUSSION
Here, we report the structure of the ADAM10 ectodomain, providing fundamental insights into how substrate selectivity (D) APP shedding assay. Cells transfected with both epitope-tagged APP (FLAG-APP-HA) and the indicated forms of ADAM10 were analyzed by western blot with anti-FLAG and anti-HA antibodies. APP shed into the media was detected with the anti-FLAG antibody, and APP present in the lysate was detected with anti-HA. The amount of material loaded into each lane was normalized by cell number and assessed by western blot analysis using an anti-GAPDH antibody. In (B) and (C), histograms represent the average of three independent transfections with measurements made in triplicate. Statistical analysis was performed using ANOVA, and a Dunnett's multiple comparison post hoc test was performed comparing test samples to the control. *p < 0.05. Error bars represent SD from the mean. See also Figure S3. and regulation of catalytic activity is achieved in this important representative of the ADAM family of metalloproteases. Fulllength ADAM precursors are catalytically inactive when the prodomain is intact, with the latent catalytic activity of the metalloprotease revealed only upon cleavage of the precursor during transport to the cell surface and release of the prodomain from the mature enzyme. The structure presented in this work reveals an unanticipated additional mode of autoregulation intrinsic to the mature enzyme, associated with an intramolecular interface between the disintegrin/cysteine rich-region and the metalloprotease active site. The masking of the active site of the enzyme by the cysteine-rich domain after prodomain release builds in a ''fail-safe'' mechanism of restricting substrate access that prevents broad-spectrum activity of the mature protease at the cell-surface, providing an additional layer of control beyond the requirement for prodomain release.
Other studies suggest that these two layers of regulation are also shared by the related ADAM family member ADAM17. Like ADAM10, ADAM17 is synthesized as a latent precursor, which requires the removal of a prodomain to be catalytically active. Studies probing the reactivity of a tight-binding inhibitor of ADAM17 indicate that inhibitor access to the active site is rapidly stimulated by a step independent of prodomain removal (Le Gall et al., 2010) . In addition, the active-site directed endogenous inhibitor TIMP3 binds with 30-fold faster association kinetics to the isolated ADAM17 catalytic domain than to the complete, mature ectodomain (Tape et al., 2011) , pointing again to an analogous autoregulatory role for the disintegrin and cysteine-rich regions in modulating access of substrates to the ADAM17 active site.
In our studies, we also observe that the disintegrin-cysteine rich region of ADAM10 exhibits dominant inhibitory activity in both Notch signaling and APP shedding assays. These findings further reinforce the notion that this portion of ADAM10 exerts an important modulatory effect on enzyme function. Previous studies have implicated the disintegrin-cysteine rich region of the metalloprotease in enzyme localization and trafficking and in substrate targeting (i.e., as an exosite binding domain). Of note, the cysteine-rich domain of all human ADAMs contains a variable sized loop of 27-55 amino acids with low sequence homology to other ADAM family proteins called the hypervariable region (HVR), which may be critical for substrate engagement. Alternatively, association of the ADAM10 disintegrin-cysteine rich region with members of the C8 family of tetraspanin proteins has been reported to facilitate ADAM10 export to the cell surface, enhancing its ability to process substrates (Dornier et al., 2012; Jouannet et al., 2016; Noy et al., 2016) . Whether the dominant-negative effect arises from competitive trans association with fully unmasked metalloprotease active sites, from competition for substrate, or from competition for binding sites on proteins associated with ADAM10 transport, such as the C8-family of tetraspanin proteins, remains to be determined.
The structural and mechanistic studies reported here suggest a model for how ligand-dependent, ADAM10-mediated proteolysis of Notch receptors takes place. The most plausible scenario ( Figure 6 ) is that transient opening of ADAM10 (over a low kinetic barrier and a relatively low value of K eq for [closed]/[open]) is permissive for capture and processing of exposed substrates, such as the mechanically exposed processing site of Notch, or the a-secretase site of APP. More tantalizing (but perhaps less likely) is the idea that the closed form of ADAM10 is assembled in a complex with Notch, arranged so that application of sufficient mechanical force to expose the Notch processing site simultaneously opens the active site of ADAM10. It is also possible that ADAM10 is localized in a microdomain on the cell surface in complex with other proteins that promote both substrate capture and activation of ADAM10. The distinct architectural features of the ADAM10 ectodomain also provide a new path forward for the development of selective modulators of ADAM10 function. Others have noted the potential of allosteric activators that stimulate a-secretase cleavage as a therapeutic approach for the treatment of Alzheimer's disease (Lammich et al., 1999; Postina et al., 2004) , and compounds that indirectly stimulate a-secretase cleavage without binding to ADAM10 are currently being explored clinically (Wetzel et al., 2017) . Conversely, stabilization of the closed conformation with an allosteric antibody or small molecule could provide greatly increased selectivity for inhibition of ADAM10 over ADAM17, analogous to highly selective allosteric inhibitors of enzymes (Chen et al., 2016) and signaling proteins (Wu et al., 2010) . Such inhibitors could find clinical application, for example, in cancers that acquire Herceptin resistance (Feldinger et al., 2014) .
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Protein for crystallography was isolated from conditioned media of Spodoptera frugiperda ovarian tissue cells (RRIB: CVCL_0549). SF9 cells were maintained in suspension growing in ESF 921 protein free insect media (Expression Systems) at 27 C. Notch and APP shedding assays were pereformed in U2OS cells (RRID: CVCL_0042). All mammalian cells were maintained at 37 C in DMEM (VWR Scientific) supplemented with 10% fetal calf serium and pen/strep.
METHOD DETAILS Protein Expression and Purification
The extracellular region of ADAM10 including the native signal peptide (residues 1-654) was amplified from a full-length ADAM10 cDNA and subcloned into the baculovirus transfer vector pVL1392 with an additional glycine at position 655 followed by a carboxyl-terminal His 6 tag. Systematic evaluation of the four potential N-linked glycosylation sites revealed that only modification of N278 was essential for proper maturation and secretion of the ectodomain, in agreement with a previous report (Escrevente et al., 2008) . We thus introduced N267Q, N439Q, and N551Q mutations into our pVL1392-ADAM10 construct, generated high-titer baculovirus stocks, and expressed this protein in insect Sf9 cells infected at a density of 4.0 3 10 6 cell/mL. Cells were incubated for an additional 72 h while shaking at 27 C. The conditioned media was isolated from the cells by centrifugation, supplemented with 20 mM Tris buffer, pH 7.5, containing 150 mM NaCl, 5 mM CaCl 2 , 1 mM NiCl 2 , and 0.01 mM ZnCl 2 , re-centrifuged to remove residual debris, and applied to a Ni-NTA column. Bound ADAM10 was washed in 20 mM Tris buffer, pH 7.5, containing 150 mM NaCl, 5 mM CaCl 2 , and eluted in the same buffer supplemented with 500 mM Imidazole. Immediately following elution, the partially purified ADAM10 was concentrated with a centrifugal filter, and isolated on an S200 size exclusion column in in 20 mM sodium cacodylate, pH 6.0, containing 150 mM NaCl, and 5 mM CaCl 2 . The peak corresponding to monomeric ADAM10 was further purified by ion exchange chromatography on a MonoS column in 20 mM Sodium Cacodylate pH 6.0, using a linear NaCl gradient. The purified protein was buffer-exchanged into 20 mM HEPES buffer, pH 7.5, containing 150 mM NaCl prior to flash freezing and permanent storage at À80
C. Ascites fluid with ADAM10 11G2 was buffered with 20 mM HEPES, pH 7.5 and captured onto Protein A-Sepharose beads. The bound antibody was extensively washed using 20 mM HEPES buffer, pH 7.5, containing 150 mM NaCl and eluted with 100 mM Glycine (pH 3.0). Elution fractions were immediately neutralized with 1 M HEPES buffer, pH 7.5 and the purity of the eluted protein was assessed on an SDS-PAGE, Coomassie-stained gel. The 11G2 F ab was generated using Ficine-Sepharose (Pierce) according to the manufacturer's instructions. The 11G2 F ab was further purified on an S200 column equilibrated in 20 mM HEPES buffer, pH 7.5, containing 150 mM NaCl. The ADAM10-11G2 F ab protein complex was formed by mixing the two components with ADAM10 in excess, and the complex was isolated from the excess ADAM10 by size exclusion chromatography on an S200 column using 20 mM HEPES buffer, pH 7.5, containing 150 mM NaCl. The protein complex was isolated and concentrated to 10 mg/mL prior to long term storage at À80 C. Crystallization, Data Collection, and Structure Determination Crystals of ADAM10 were grown in 24-well format hanging drops at room temperature. ADAM10 (2.5 mg/mL) crystals grew after 5 d in 0.26 M ammonium sulfate, 100 mM HEPES pH 7.5, 21.75% PEG8000. Crystals were cryoprotected by supplementing the mother liquor with 10% glycerol (v/v). Individual crystals were flash frozen in liquid nitrogen and stored until data collection. Data collection was performed at Advanced Photon Source NE-CAT beamline 24 ID-C. Diffraction images were processed and scaled using XDS (Kabsch, 2010) . To obtain phases, molecular replacement for all four copies was performed in Phenix with Phaser (McCoy et al., 2007) using chain A from the ADAM17 metalloproteinase structure, PBD ID 1BKC (Maskos et al., 1998 ) as the search model. A subsequent molecular replacement search was performed, using the catalytic domain as a fixed partial solution, with a structure of the bovine ADAM10 disintegrin-cysteine rich region fragment, PDB ID 2AO7 (Janes et al., 2005) as the search model. Iterative model building and reciprocal space refinement was performed in COOT (Emsley and Cowtan, 2004) and phenix.refine (Afonine et al., 2012) , respectively. Reciprocal space refinement used reciprocal space optimization of xyz coordinates, individual atomic B-factors, NCS restraints, optimization for X-ray/stereochemistry weights, and optimization for X-ray/ADP weights. Model quality was evaluated using composite omit density maps. In final cycles of model building, NCS restraints were removed. Final model quality was assessed using MolProbity . All crystallographic data processing, refinement, and analysis software was compiled and supported by the SBGrid Consortium (Morin et al., 2013) . Data acquisition and refinement statistics are presented in Table 1 . Figures were prepared using Pymol (Schrö dinger).
Initial crystals of the ADAM10-11G2 F ab complex were grown in 24-well hanging drops at room temperature in 2.0 M ammonium sulfate, 100 mM Tris buffer, pH 8.5, containing 2% PEG400. These crystals were crushed to create a microseed stock, and used to grow additional single crystals at room temperature in 2.23 M ammonium sulfate, 100 mM Tris buffer, pH 8.5, containing 2% PEG400. These crystals were cryoprotected by supplementing with 10% glycerol, flash frozen, and stored in liquid nitrogen until data collection.
Data collection for the ADAM10-F ab complex was performed at Advanced Photon Source NE-CAT beamline 24 ID-C and GM/CA beamline 23 ID-B. The complete dataset was obtained by merging diffraction data from two isomorphic crystals in XDS. Initial phases were obtained by molecular replacement using F ab heavy and light chains from PDB ID 1YQV (Cohen et al., 2005) followed by placement of the ADAM10 model generated above. Iterative model building and reciprocal space refinement was performed in COOT and phenix.refine, respectively. Phenix.refine used reciprocal space optimization of xyz coordinates, individual atomic B-factor, optimization for X-ray/stereochemistry weights, and optimization for X-ray/ADP weights. Data acquisition and refinement statistics are presented in Table 1 .
Single-particle EM analysis Samples were prepared for electron microscopy using a conventional negative staining protocol (Peisley and Skiniotis, 2015) . The negative stained samples were imaged at room temperature with a Tecnai T12 electron microscope operated at 120 kV using low-dose procedures. Images were recorded at a magnification of 3 71,138 and a defocus value of $1.2 mm on a Gatan US4000 CCD camera. All images were binned (2 3 2 pixels) to obtain a pixel size of 4.16 Å on the specimen level. A total of 19,227 particle projections were excised using Boxer (part of the EMAN 2.1 software suite) (Ludtke et al., 1999) and subjected to two-dimensional reference-free alignment and classification using ISAC (Yang et al., 2012) . Representative class averages are shown in Figure S2 . 3D classification and reconstruction was performed with RELION (Scheres, 2012 (Scheres, , 2016 . An ab initio model generated with VIPER (Penczek et al., 1994) using ISAC 2D averages was used as an initial reference model for maximum-likelihood-based 3D classification of 12,893 particle projections. One stable class accounting for 3,491 particles showed detailed features for both components of the complex and was subjected to 3D refinement. The resulting 3D reconstruction with docked X-ray structure of the ADAM10-11G2 F ab complex is shown in Figure S2C .
Sequence Conservation Analysis
For conservation analysis, we analyzed 356 ADAM10 genes from bilateria, using output from the Consurf Seq server. The multiple sequence alignment and the ADAM10 atomic model were then analyzed using the Consurf server, and visualized using default Consurf parameters and colors in Pymol.
Fluorescent ADAM10 Peptide Cleavage Assay Purified ADAM10, antibody 11G2, and antibody 8C7 were buffer-exchanged into ADAM10 reaction buffer, which consisted of 25 mM Tris, pH 9.0, containing 2 mM ZnCl 2 , and 0.005% (w/v) Brij-35. ADAM10 (0.5 mM)-antibody complexes were formed by pre-equilibration for 30 min prior to initiation of the peptide cleavage assay. Peptide cleavage was initiated by mixing 30 mM of a fluorogenic peptide substrate, Mca-PLAQAV-Dpa (R&D Systems Cat# ES003) with ADAM10-antibody complexes at 37 C, monitoring the progress of reaction by fluorescence emission (l ex = 320 nm and l em = 405 nm) over a time course of 1 h using a SpectraMax M5 Microplate Reader (Molecular Devices).
Cell Lines
All cell lines used in this study (U2OS, MS5, and MS5-DLL4) have been described previously and were maintained in DMEM supplemented with 10% fetal bovine serum and penicillin/streptomycin (Andrawes et al., 2013). To generate an ADAM10 À/À U2OS cell line, the MIT CRISPR guide design server (http://crispr.mit.edu) was used to select guide sequences targeting exon 1 of the ADAM10 gene. DNA guide sequences were purchased (IDT Technologies), annealed in 10 mM Tris, 50 mM NaCl, pH 8, and then subcloned into a pSpCas9 WT-2A-GFP vector using a BsmBI restriction site compatible with overhangs designed into the annealed duplex. The resulting pSpCas9-ADAM10exon1 cDNA was transfected into U2OS cells using Lipofectamine 2000 (Invitrogen). Cells expressing GFP were sorted into 96-well plates by flow cytometry 48-72 h after transfection. Clonal populations were allowed to expand for 2-3 weeks and genomic DNA was extracted from individual clones. For each clone, the targeted ADAM10 locus was amplified by PCR and TOPO-cloned (Invitrogen) for sequencing. A minimum of 10 clones per cell line were analyzed to confirm the presence of targeted mutations in ADAM10 exon1. The loss of ADAM10 expression was verified by western blotting with an anti-ADAM10 antibody (Millipore).
Notch Co-culture Assay
To investigate the role of ADAM10 in Delta-like4 (DLL4) stimulated Notch processing, we used a luciferase reporter co-culture assay in which the intracellular ankyrin-repeat domain of Notch is replaced with the Gal4 DNA-binding domain (Andrawes et al., 2013; Aster et al., 2000) . On day 1, U2OS cells in 6-well plates were transfected with a reporter mix containing 1.0 mg Gal4-Luciferase, 0.02 mg pRenilla, 0.75 mg Notch1-Gal4, and 0.75 mg of pRK5M-ADAM10 or pcDNA3.1 using Lipofectamine 2000. On the following day, transfected cells were split and mixed with either MS5 control or MS5-DLL4 ligand-expressing cells, and then the mixed cells were cocultured in 96-well plates. Ater 24 h of co-culture, firefly and Renilla luciferase activities were measured in triplicate on a dual-injector luminometer (Turner Systems) using the Dual Luciferase Assay Kit (Promega). The ratio of firefly to Renilla activity in the co-culture with MS5 cells alone (negative control) was normalized to a value of 1. Statistical analysis on three independent transfections was performed using ANOVA, and a Dunnett's multiple comparison post hoc test was performed using GraphPad Prism software (version 5.0). *p < 0.05. ADAM10 rescue studies and analysis of dominant-negative activity of ADAM10 mutants were performed with sequences subcloned into the backbone of the parental pRK5M-ADAM10myc tag plasmid (Addgene #31717) using Infusion ligation (Clonetech). The ADAM10 signal sequence was fused to E454 and A655 for the DMP and DEC constructs, respectively.
Cellular APP Processing Assay
To create a form of APP with an N-terminal FLAG epitope and a C-terminal HA epitope, a C-terminal HA epitope tag was inserted into the FLAG-APP plasmid pCAX FLAG-APP (Addgene #30154) by anchored PCR mutagenesis. To probe APP ectodomain release, U2OS cells in 6-well plates were transfected with 1 mg of pCAX FLAG-APP-HA, ADAM10 (varying amounts), and pcDNA3.1 to maintain a consistent total amount of 2 mg DNA/well. The following day, the transfected cells were washed with PBS, the media was replaced, and in some cases was supplemented with 1 mM BB94 or 1 mM Compound E. After an additional 24 h, the conditioned media was analyzed by SDS-PAGE followed by western blotting with an a-FLAG antibody (M1) to detect APP shedding. The cells were washed extensively and the lysate was similarly analyzed by SDS-PAGE and western blotting using the same a-FLAG antibody and an a-HA antibody (Abcam) to assess the amount of APP remaining in the cell lysate.
QUANTIFICATION AND STATISTICAL ANALYSIS
Bar graphs display the mean ± SD from three independent transfections. P values were calculated by one-way ANOVA, and a Dunnett's multiple comparison post hoc test was performed using GraphPad Prism software (version 5.0). *p < 0.05.
DATA AND SOFTWARE AVAILIBILITY
The accession numbers for the two structures reported in this paper are RCSB PDB: 6BE6 and 6BDZ. The Consurf server is a freely available online tool for academic end users developed and maintained by the Ben-Tal laboratory at Tel Aviv University, Israel. All software used for structure determination (XDS, Phenix, Pymol and Coot) is accessible from the Structural Biology Grid (SBGrid) Consortium at Harvard Medical School. (C) Molecular surface showing the envelope of the ADAM10-Fab complex determined using negative stain electron microscopy, contoured at 3s. The inset to the right shows the particle class average that fits most closely to the orientation of the X-ray structure shown within the negative stain surface envelope. Error bars represent SD from the mean.
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